{"id":1294,"date":"2024-03-08T17:15:34","date_gmt":"2024-03-08T17:15:34","guid":{"rendered":"https:\/\/www.asklepios-advisors.com\/?page_id=1294"},"modified":"2024-03-12T13:48:58","modified_gmt":"2024-03-12T13:48:58","slug":"karl-mahler","status":"publish","type":"page","link":"https:\/\/www.asklepios-advisors.com\/index.php\/karl-mahler\/","title":{"rendered":"Karl\u00a0Mahler"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Capture\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Karl Mahler
Senior Advisor<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Experience \u2013 \ud83c\udde8\ud83c\udded \ud83c\udde9\ud83c\uddea<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Karl Mahler is a top-notch executive with extensive corporate planning and Investors relations experience in the pharmaceutical & diagnostic industry.\u00a0<\/p>

Karl is a Seasoned healthcare executive with over 30 years\u2019 experience including Head of Investor Relations, Member of an Investment Committee of a Pension Fund and Corporate ESG activities respectively for Roche, Novartis and Aventis.

Karl founded Germany\u2019s largest Cancer Research Clinic in Freiburg i. Brsg. and created two Joint Ventures in China as General Manager.

Rewarded for Investor oriented focus, Karl has a global investors network and recently elected as the first member in the Hall of Fame of Global Executives in the Financial Industry by Institutional Investor.\u00a0<\/p>

Karl holds a PhD in Mathematical Economics from Freiburg University.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CONTACT :\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tLinkedin<\/span>\n\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\tEnvelope<\/span>\n\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t<\/a>\n\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Karl MahlerSenior Advisor Experience \u2013 \ud83c\udde8\ud83c\udded \ud83c\udde9\ud83c\uddea Karl Mahler is a top-notch executive with extensive corporate planning and Investors relations experience in the pharmaceutical & diagnostic industry.\u00a0 Karl is a Seasoned healthcare executive with over 30 years\u2019 experience including Head of Investor Relations, Member of an Investment Committee of a Pension Fund and Corporate ESG […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1294","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/pages\/1294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/comments?post=1294"}],"version-history":[{"count":7,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/pages\/1294\/revisions"}],"predecessor-version":[{"id":1596,"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/pages\/1294\/revisions\/1596"}],"wp:attachment":[{"href":"https:\/\/www.asklepios-advisors.com\/index.php\/wp-json\/wp\/v2\/media?parent=1294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}